Empagliflozin-Induced Acute Pancreatitis and Euglycemic Diabetic Ketoacidosis in Type 2 Diabetes Mellitus. Am. J. Chem. Pharm. 2022, 1 (2), 1-4. https://doi.org/10.54536/ajcp.v1i2.747.